April 28, 1998
AMERIPATH, INC. ANNOUNCES EXPANDED LINE OF CREDIT TO FUND ACQUISITIONS

Riviera Beach, FL, April 28, 1998---AmeriPath, Inc. (Nasdaq: PATH), a physician practice management company focused on anatomic pathology services announced today that it has obtained a $200 million revolving credit facility from a syndicate of financial institutions lead by co-agents BankBoston and NationsBank. This facility provides the Company with increased availability of funding and on more favorable terms, to increase its presence and visibility within the pathology marketplace.

"AmeriPath is extremely pleased to have the continued support of a syndicate of eleven of the country's leading financial institutions and particularly the leadership of such stalwarts as the syndicate's co-agents BankBoston and NationsBank," said Jim New, AmeriPath's President and Chief Executive Officer.

As stated by Greg O'Brien, Managing Director of BankBoston, "We are pleased to be a strategic banking partner with AmeriPath as they continue to grow, and look forward to working with them and the assembled group of Banks as the Company pursues its strategy. The size of the new credit facility and the quality of the bank group reflects confidence in senior management to successfully execute their strategy."

The Company will use one facility to refinance the $81 million outstanding under its credit facility and the balance to continue its acquisition program. AmeriPath expects to increase its presence in existing markets as well as enter into new markets in the Midwest, Southeast, South Central and Northeast regions of the U.S. through the acquisition and affiliation with leading pathology practices. AmeriPath's strategy to partner with prominent pathology practices nationwide facilitates the expansion and development of the Company's regional business model.

AmeriPath, Inc. believes it is the nation's leading physician practice management company focused on providing anatomical pathology services to physicians, hospitals, national clinical laboratories and managed care organizations. The Company presently operates 18 physician practices in eight states, employs more than 145 pathologists and provides medical services through outpatient pathology laboratories, hospital inpatient laboratories and outpatient surgery centers.

................................................................................................................

This release contains certain forward-looking statements regarding AmeriPath, including its operations and prospects. Past performance is not necessarily indicative of future results. In addition, AmeriPath's actual results could differ materially from the results anticipated in these forward-looking statements as a result of uncertainties, including risks relating to demand, pricing, government regulation, payments and reimbursements, dependence upon contacts and pathologists, the market for pathology services, competition, and other factors identified in AmeriPath's filings with the Securities and Exchange Commission.